U.S. regulators say the Baltimore factory contracted to make Johnson & Johnson's COVID-19 vaccine was dirty, didn't follow proper manufacturing procedures and had poorly trained staff. The problems resulted in contamination of a batch of material that was going to be put in the shots. The FDA released a 13-page report detailing findings from its recent inspection of the now-idle Emergent Biosciences factory. J&J and Emergent say they're working to fix the problems, but it begs the question: will J&J be able to regain the public's trust?
Create your
podcast in
minutes
It is Free